Axonal Transport of Human Immunodeficiency Virus Type 1 Envelope Protein Glycoprotein 120 Is Found in Association with Neuronal Apoptosis
Open Access
- 21 June 2006
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 26 (25), 6771-6780
- https://doi.org/10.1523/jneurosci.1054-06.2006
Abstract
Patients infected by human immunodeficiency virus type 1 (HIV-1) develop acquired immune deficiency syndrome-associated dementia complex (ADC), a disorder characterized by a broad spectrum of motor impairments and cognitive deficits. The number of cells in the brain that are productively infected by HIV-1 is relatively small and consists predominantly of macrophages and microglia, yet HIV-1 causes widespread neuronal loss. A better understanding of the pathogenic mechanisms mediating HIV-1 neurotoxicity is crucial for developing effective neuroprotective therapies against ADC. The HIV-1 envelope glycoprotein 120 (gp120), which is shed from the virus, is one of the agents causing neuronal cell death. However, the cellular mechanisms underlying its neurotoxic effect remain unclear. We report that gp120 injected into the rat striatum or hippocampus is sequestered by neurons and subsequently retrogradely transported to distal neurons that project to these brain areas. Cleaved caspase-3 and terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling, hallmarks of apoptosis, were seen in neurons internalizing and transporting gp120. The retrograde transport of gp120 and apoptosis were mediated by the chemokine receptor CXCR4 because AMD3100, a selective CXCR4 inhibitor, blocked both events. Furthermore, colchicine or nocodazole, two inhibitors of intracellular trafficking, abolished gp120-mediated apoptosis in distal areas. These results indicate that axonal transport of gp120 might play a role in HIV-1-mediated widespread neuronal cell death.Keywords
This publication has 59 references indexed in Scilit:
- Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virusVirus Research, 2005
- The neuropathogenesis of AIDSNature Reviews Immunology, 2005
- Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain‐derived neurotrophic factor in vivo: potential implication for neuronal cell deathEuropean Journal of Neuroscience, 2004
- The chemokine receptor CXCR4 and not the N‐methyl‐D‐aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cellsJournal of Neuroscience Research, 2003
- Role of the α‐chemokine stromal cell‐derived factor (SDF‐1) in the developing and mature central nervous systemGlia, 2003
- Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and ß-arrestin proteinsProgress in Neurobiology, 2001
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4Current Biology, 1998